Erste Asset Management’s Coherus Oncology CHRS Stock Holding History

Erste Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$1.76M	–	502
2020 Q4	$1.76M	Hold	100,000	–	–	0.05%	286
2020 Q3	$1.83M	Sell	100,000 -56,000	-36%	-$1.04M	0.06%	258
2020 Q2	$2.76M	Hold	156,000	–	–	0.11%	190
2020 Q1	$2.56M	Hold	156,000	–	–	0.15%	164
2019 Q4	$2.77M	Hold	156,000	–	–	0.12%	170
2019 Q3	$3.17M	Hold	156,000	–	–	0.17%	136
2019 Q2	$3.41M	Buy	+156,000	New	+$2.71M	0.18%	132
2019 Q1	–	Sell	-27,600	Closed	-$243K	–	419
2018 Q4	$243K	Buy	+27,600	New	+$319K	0.02%	351

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Erste Asset Management's CHRS Position: Q1 2021 in Review

Erste Asset Management sold out of Coherus Oncology (CHRS) in Q1 2021, closing a stake of 100,000 shares — an estimated $1.76M sold.

Erste Asset Management first reported a position in CHRS in Q4 2018 and held it in 8 quarters. The position peaked at $3.41M in Q2 2019. 205 funds tracked by Wall St. Rank hold CHRS as of Q1 2021.

Erste Asset Management reported no remaining Coherus Oncology position as of Q1 2021 after selling out during the quarter.
Erste Asset Management sold 100,000 Coherus Oncology shares in Q1 2021, an estimated $1.76M.
Erste Asset Management first reported a position in Coherus Oncology in Q4 2018 and held it in 8 quarters.
Erste Asset Management's Coherus Oncology position peaked at $3.41M in Q2 2019.
205 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2021.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.